Press release
AI in Epidemiology Market to Reach USD 3.3 Billion by 2035 | AI-Driven Disease Surveillance, Predictive Analytics & Digital Health Fuel Growth
AI in Epidemiology Market
According to Market Genics, the AI in Epidemiology Market is projected to grow from USD 0.4 Billion in 2025 to USD 3.3 Billion by 2035, registering a robust CAGR of 24.1% during the forecast period. The market is experiencing rapid expansion as governments, healthcare organizations, and research institutions increasingly leverage artificial intelligence (AI), machine learning (ML), predictive analytics, and big data to monitor disease outbreaks, forecast epidemics, and improve public health responses. The growing prevalence of infectious diseases, rising investments in digital healthcare infrastructure, and the increasing need for real-time disease surveillance are driving widespread adoption of AI-powered epidemiology solutions. AI-enabled platforms are transforming public health by enhancing outbreak prediction, contact tracing, population health management, and clinical decision-making, making epidemiology more proactive and data-driven.
Get Free Sample PDF Brochure: https://marketgenics.co/download-report-sample/ai-in-epidemiology-market-01366?utm_source=Open+pr&utm_medium=ruchika
➤ Growth Snapshot
The AI in Epidemiology Market is gaining momentum due to the increasing integration of AI technologies into disease surveillance and public health systems. Governments and healthcare agencies are investing in AI-powered epidemic forecasting tools to strengthen pandemic preparedness and improve healthcare outcomes. Advances in natural language processing (NLP), computer vision, cloud computing, geospatial analytics, wearable health technologies, and Internet of Medical Things (IoMT) are enabling faster identification of disease trends and more accurate predictive modeling. Growing collaborations among technology companies, healthcare providers, pharmaceutical firms, and public health organizations are expected to further accelerate market growth through 2035.
➤ Market Key Players
• Microsoft Corporation
• Google LLC
• IBM Corporation
• Oracle Corporation
• SAS Institute Inc.
• Palantir Technologies Inc.
• IQVIA Holdings Inc.
• NVIDIA Corporation
• Amazon Web Services (AWS)
• Siemens Healthineers
• Tempus AI
• C3 AI
• Philips Healthcare
• Epic Systems Corporation
• GE HealthCare Technologies Inc.
Buy Now Premium Research Report: https://marketgenics.co/buy/ai-in-epidemiology-market-01366?utm_source=Open+pr&utm_medium=ruchika
➤ Market Segmentation
The AI in Epidemiology Market is segmented by component, deployment mode, technology, application, end user, and region. Based on component, the market includes software, services, and AI platforms. By deployment mode, it is divided into cloud-based and on-premise solutions. Based on technology, the market comprises machine learning, deep learning, natural language processing (NLP), computer vision, predictive analytics, and big data analytics. Applications include disease surveillance, outbreak prediction, contact tracing, population health management, pandemic preparedness, vaccine monitoring, healthcare resource optimization, and clinical decision support. End users include government health agencies, hospitals, research institutes, pharmaceutical companies, biotechnology firms, public health organizations, and academic institutions.
➤ Market Analysis and Insights
The AI in Epidemiology Market is reshaping global healthcare by enabling early disease detection, improving outbreak forecasting, and enhancing healthcare resource planning. AI-powered epidemiological models analyze vast amounts of structured and unstructured health data from electronic health records, laboratory systems, wearable devices, social media, and environmental sources to identify emerging health threats. Increasing investments in AI-driven public health infrastructure, digital epidemiology, and precision public health initiatives are creating significant growth opportunities. Furthermore, cloud computing, edge AI, and interoperable healthcare data platforms are enhancing scalability and real-time analytics capabilities. As healthcare systems continue to prioritize preventive care and rapid response strategies, AI-driven epidemiology solutions are expected to play an increasingly vital role in disease prevention and global health security.
➤ Segmentation and Targeting
The AI in Epidemiology Market report is designed for healthcare organizations, government agencies, pharmaceutical companies, biotechnology firms, AI software developers, healthcare IT providers, research institutions, contract research organizations (CROs), public health authorities, hospitals, and investors. It provides valuable insights for stakeholders involved in AI healthcare solutions, disease surveillance systems, predictive analytics, healthcare data management, precision public health, epidemic intelligence, and digital health innovation. Organizations seeking to develop AI-powered epidemiology platforms, enhance public health infrastructure, or expand into digital healthcare markets will benefit from this comprehensive analysis.
Browse In-depth Market Research Report: https://marketgenics.co/reports/ai-in-epidemiology-market-01366?utm_source=Open+pr&utm_medium=ruchika
➤ Geographical Landscape
North America dominates the AI in Epidemiology Market due to its advanced healthcare infrastructure, strong AI ecosystem, high healthcare spending, and significant investments in digital health technologies. The United States leads in AI-based disease surveillance, predictive analytics, and healthcare innovation. Europe follows with substantial investments in public health digitization, AI research, and healthcare data interoperability across countries such as Germany, the United Kingdom, France, and the Netherlands. The Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing healthcare digitization, expanding AI adoption, rising government initiatives, and growing investments in healthcare infrastructure across China, Japan, India, South Korea, Singapore, and Australia. Latin America and the Middle East & Africa are also gradually adopting AI-enabled epidemiology solutions to strengthen disease surveillance and healthcare preparedness.
➤ Questions Answered by the Report
• What is the current size of the AI in Epidemiology Market?
• What will be the market value by 2035?
• What is the projected CAGR during 2025-2035?
• Which AI technologies are driving disease surveillance and epidemiology?
• What are the major applications of AI in epidemiology?
• Who are the leading companies operating in the AI in Epidemiology Market?
• Which region dominates the global market?
• Which region is expected to register the fastest growth?
• What are the major growth drivers, challenges, and opportunities?
• How will AI, predictive analytics, and digital health transform epidemiology over the next decade?
➤ Discover More Research Reports By MarketGenics:
Connected Ambulance Systems Market - https://www.openpr.com/news/4585511/connected-ambulance-systems-market-to-reach-usd-0-6-billion
Smart ICU Systems Market - https://www.openpr.com/news/4585515/smart-icu-systems-market-to-reach-usd-27-6-billion-by-2035-as-ai
AI-based Pathology Market - https://www.openpr.com/news/4585520/ai-based-pathology-market-to-reach-usd-0-8-billion-by-2035-as
Smart Implants Market - https://www.openpr.com/news/4585526/smart-implants-market-to-reach-usd-7-2-billion-by-2035-as-ai
AI in Hospital Operations Market - https://www.openpr.com/news/4585528/ai-in-hospital-operations-market-to-reach-usd-61-5-billion-by-2035
About MarketGenics
MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.
MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.
In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.
Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Epidemiology Market to Reach USD 3.3 Billion by 2035 | AI-Driven Disease Surveillance, Predictive Analytics & Digital Health Fuel Growth here
News-ID: 4587329 • Views: …
More Releases from MarketGenics Global Research
Rubber Tire Market to Reach USD 281.7 Billion by 2035 | EV Tires, Smart Tire Tec …
➤ Market Overview
According to Market Genics, the Rubber Tire Market is valued at USD 184.9 Billion in 2025 and is projected to reach USD 281.7 Billion by 2035, expanding at a CAGR of 4.3% during the forecast period. Market growth is fueled by increasing global vehicle production, rising demand for replacement tires, rapid expansion of electric vehicles (EVs), and continuous advancements in tire manufacturing technologies. The growing emphasis on fuel-efficient,…
AI in Genomics Market to Reach USD 6.5 Billion by 2035 | Precision Medicine, Nex …
➤ Market Overview
According to Market Genics, the AI in Genomics Market is estimated at USD 0.6 Billion in 2025 and is projected to reach USD 6.5 Billion by 2035, expanding at a robust CAGR of 27.8% during the forecast period. The market is experiencing substantial growth as artificial intelligence (AI), machine learning (ML), deep learning, and advanced bioinformatics revolutionize genomic research and precision medicine. AI-powered genomics solutions are enabling researchers…
AI in Clinical Trials Market to Reach USD 2.7 Billion by 2035 | AI, Machine Lear …
➤ Market Overview
According to Market Genics, the AI in Clinical Trials Market is projected to grow from USD 1.1 Billion in 2025 to USD 2.7 Billion by 2035, registering a remarkable CAGR of 9.2% during the forecast period. The market is witnessing rapid expansion due to the increasing adoption of artificial intelligence (AI), machine learning (ML), predictive analytics, natural language processing (NLP), and automation across clinical research processes. AI technologies…
Personalized Oncology Market to Reach USD 18.4 Billion by 2035 | Precision Medic …
➤ Personalized Oncology Market Overview
The Personalized Oncology Market is witnessing remarkable growth as precision medicine transforms the future of cancer diagnosis and treatment. According to Market Genics, the global Personalized Oncology Market is estimated at USD 7.7 Billion in 2025 and is projected to reach USD 18.4 Billion by 2035, expanding at a CAGR of 9.1% during the forecast period. The increasing adoption of genomic sequencing, biomarker-based therapies, AI-powered oncology…
More Releases for Epidemiology
Gastritis Market and Epidemiology 2032: Treatment Market, Therapies, Companies, …
The Gastritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gastritis pipeline products will significantly revolutionize the Gastritis market dynamics.
DelveInsight's "Gastritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Gastritis, historical and forecasted epidemiology as well as the Gastritis market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Global Anaplastic Astrocytoma Market Insight, Epidemiology and Market Forecast- …
The Anaplastic Astrocytoma Market Report, 2020 - gives a Detailed Description Of The Drug Is Proffered Including Mechanism Of Action Of The Drug, Clinical Studies, NDA Approvals (If Any), And Product Development Activities Comprising The Technology, Anaplastic Astrocytoma Collaborations, Licensing, Mergers And Acquisition, Funding, Designations, And Other Product-Related Details.
Get a sample copy of the report at- https://www.marketreportsworld.com/enquiry/request-sample/12978465
Anaplastic Astrocytoma Product Profiles & Analysis
The drug chapter segment covers the…
Global Urinary Incontinence Market Insight, Epidemiology and Market Forecast- In …
The Urinary Incontinence Market Report, 2020 - gives a Detailed Description Of The Drug Is Proffered Including Mechanism Of Action Of The Drug, Clinical Studies, NDA Approvals (If Any), And Product Development Activities Comprising The Technology, Urinary Incontinence Collaborations, Licensing, Mergers And Acquisition, Funding, Designations, And Other Product-Related Details.The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.
Get a sample copy of…
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis.
Download the sample report @ https://www.pharmaproff.com/request-sample/1159
The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the…
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with…
Nasopharyngeal Cancer Market Epidemiology, Disease Type, Product Description, Di …
Nasopharyngeal Cancer Market Epidemiology outlays comprehensive Insight of the disease, historical & forecasted epidemiology as well as the market trends of Nasopharyngeal Cancer Industry. The Report provides a detailed picture of the current treatment practices, emerging drugs, a market share of the individual therapies, current and forecasted market size of Nasopharyngeal Cancer.
The Nasopharyngeal Cancer Market Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to…
